Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 29, 2010Menopause The Journal of The North American Menopause Society

Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea

View Full Paper
Ask AI
Bookmark
Share

Authors

SNSafa NajafiAhvaz Jundishapur University of Medical SciencesGDGholamreza Esmaeeli DjavidAcademic Center for Education, Culture and ResearchNMNeda MehrdadResearch Institute for Endocrine Sciences

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Najafi et al. (2010) studied this question.

synapsesocial.com/papers/6a027d27f57c648cc201d5echttps://doi.org/10.1097/gme.0b013e3181f3e6e7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Incidence, Time Course, and Determinants of Menstrual Bleeding After Breast Cancer Treatment: A Prospective Study2006 · 437 citations
  2. 2Incidence and Prognostic Impact of Amenorrhea During Adjuvant Therapy in High-Risk Premenopausal Breast Cancer: Analysis of a National Cancer Institute of Canada Clinical Trials Group Study—NCIC CTG MA.52005 · 131 citations
  3. 3Taxanes for adjuvant treatment of early breast cancer2007 · 193 citations